Moreover, mutations of TET2 and IDH1/2 (both the enzymes are involved in shaping DNA epigenetic modifications) belong to the driving mutations that are acquired with the evolution of MDS to AML [47]. The gene discussed is TET2; the disease is acute myeloid leukemia.